References
- Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994).
- ZECKEL ML, WOODWORTH JR: Vancomycin: a clinical overview. In: Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994):309–409.
- GOLDSTEIN B, ROSINA R, PARENTI F: Teicoplanin. In: Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994):273–307.
- SPELLER DCE, LYNN WA, ROGERS TR: Glycopeptide resis-tance in Gram-positive bacteria. Clin. Microbiol. Infect. (1995) 1:54–59.
- NICAS TI, ALLEN NE: Resistance and mode of action. In: Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994):219–241.
- NICAS TI: Activity of novel semi-synthetic glycopeptides against Vancomycin-resistant enterococcL Program Abstr. 7th Eur. Cong. Clin. Micro biol. Infect. Dis. (1995) Abstr. 560.
- NICAS TI et al.: Semisynthetic glycopeptides activeagainst Vancomycin-resistant enterococci: activity against staphylococci and streptococci in vitro and in vivo. Program Abstr. 35th Intersc. Conf Antimicrob. Agents Chemother: Abstr. F248.
- BOYLAN CJ etal.: Efficacy of semisynthetic glycopeptideactive against Vancomycin-resistant enterococci in a mouse infection model Program Abstr. 35th Intersc. Conf Antimicrob. Agents Chemother : Abstr. F255.
- BUGG TDH et al.: Molecular basis for Vancomycin resis-tance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by Van-comycin-resistance proteins VanH and VanA. Biochem-istty (1991) 30:10408–10415.
- WOODFORD NjOHNSON A: Glycopeptide resistance in Gram-positive bacteria: from black and white to shades of grey. J. Med. Microbiol. (1994) 40:375–378.
- LETOURNEAU DL, HOBBS JN, ALLEN NE: Molecular inter-actions of LY264826 and its p-chlorobenzyl derivative, LY19114S, with dipeptidyl and depsipeptidyl ligands. Program Abstr. 35th Intersc. Conf. Antimictrob. Agents Chemother: Abstr. F251.
- ZECKEL ML, WOODWORTH JR: Vancomycin safety. In:Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994):219–241.
- NICAS TI et al.: Semisynthetic glycopeptides active against Vancomycin-resistant enterococci: in vitro ac-tivity against enterococci. Program Abstr. 35th Intersc. Conf Antimicrob. Agents Chemother: Abstr. F249.
- LIN Y etal.: Non-clinical pharmacokinetics of LY333328, a semisynthetic glycopeptide antibiotic active against vancomycin-resistant enterococcL Program Abstr. 35th Intersc. Conf Antimicrob. Agents Chemother: Abstr, F254.
- MALABARBA A et al.: Amides of de-acetylglucosaminyl-deoxy Teicoplanin active against highly glycopeptide resistant enterococci. I Antibiot. (1994) 47:1493–1506.
- MALABARBA A etal.: New semisynthetic glycopeptides MDL63, 246 and MDL63, 042 and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide resistant VanA enterococci j Antibiot. 48:869–883.